Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Deborah Marcellus"'
Autor:
Douglas A. Stewart, Lois E. Shepherd, Jill J. Dudebout, Jean-François Larouche, Neil Chua, Tara Baetz, Michael Crump, Mona Shafey, Nizar Abdel-Samad, Sue Robinson, Isabelle Fleury, Deborah Marcellus, Pamela Skrabek, Jesse Kelly, Annette E. Hay, Bingshu Chen, John Kuruvilla
Publikováno v:
Blood. 140:3734-3736
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ac35ce10ca77332275b68840f85d416
https://doi.org/10.1182/blood-2022-163706
https://doi.org/10.1182/blood-2022-163706
Autor:
Stephen Couban, James R. Cook, Kevin Barton, Pierluigi Porcu, Louis S. Constine, Patrick J. Stiff, Stephen J. Forman, Glenn Mills, Thomas C. Shea, Richard I. Fisher, Douglas A. Stewart, John P. Leonard, Hongli Li, Jonathan W. Friedberg, Brad S. Kahl, Michael LeBlanc, Jane N. Winter, Sonali M. Smith, Zeina Al-Mansour, Lisa M. Rimsza, Deborah Marcellus
Publikováno v:
Leuk Lymphoma
Phase II data suggest a benefit to autotransplantation for aggressive T-NHL in first remission; randomized trials have yet to validate this. We performed a retrospective analysis of aggressive T-NHL patients in the intergroup randomized consolidative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f473668d7eaadf84539369c5458fccf
https://doi.org/10.1080/10428194.2018.1563691
https://doi.org/10.1080/10428194.2018.1563691
Autor:
Donna E. Reece, Guy Cantin, A. Keith Stewart, Jean Roy, Morel Rubinger, Erica L. Harnett, Tony Reiman, Deborah Marcellus, Martha Q. Lacy, Lois E. Shepherd, Jonathan Sussman, Nizar J. Bahlis, Michael Brundage, Waleed Sabry, K. Song, Kirsty A. Tompkins, Suzanne Trudel, Darrell White, Ralph M. Meyer, Andrew Belch, Judy Anne W. Chapman, Michael J. Kovacs, Chaim Shustik
Publikováno v:
Blood. 121:1517-1523
We conducted a randomized, controlled trial comparing thalidomide-prednisone as maintenance therapy with observation in 332 patients who had undergone autologous stem cell transplantation with melphalan 200 mg/m2. The primary end point was overall su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e326c14a917468d9f454b4596a446090
https://doi.org/10.1182/blood-2012-09-451872
https://doi.org/10.1182/blood-2012-09-451872
Autor:
Lisa M. Rimsza, James R. Cook, Thomas C. Shea, Deborah Marcellus, Patrick J. Stiff, Hongli Li, Stephen Couban, Soham D. Puvvada, Brad S. Kahl, John P. Leonard, Jonathan W. Friedberg, Jane N. Winter, Sonali M. Smith, Michael LeBlanc
Double hit lymphoma (DHL) and double protein-expressing (MYC, BCL2) lymphomas (DPL) fare poorly with R-CHOP (rituximab + cyclophosphamide, doxorubicin, vincristine, prednisolone); consolidative autologous stem cell transplant (ASCT) may improve outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cf12d61745771254df0379ab37df251
https://europepmc.org/articles/PMC5125530/
https://europepmc.org/articles/PMC5125530/
Autor:
Ralph M. Meyer, Sarah Mathews, Michael J. Kovacs, Rui-Ping Dong, Donna E. Reece, Deborah Marcellus, Elizabeth Eisenhauer
Publikováno v:
Investigational New Drugs. 24:529-535
Multiple myeloma is a disease in which angiogenesis is postulated to be a target for therapy. Based on this hypothesis, we conducted a phase II trial of ZD6474 (Zactima™; a VEGFR inhibitor) 100 mg p.o. daily in patients with relapsed multiple myelo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b0ec6bc134b439b85d5182342278807
https://doi.org/10.1007/s10637-006-9022-7
https://doi.org/10.1007/s10637-006-9022-7
Autor:
C. Tom Kouroukis, Ronan Foley, A. Benger, Ralph M. Meyer, George P. Browman, Deborah Marcellus
Publikováno v:
Leukemia & Lymphoma. 45:2471-2476
Health related quality of life is an important outcome measure. With aging, patients may experience changes in physical, socioeconomic and psychological functioning. This pilot study examined whether age influences the level of importance that patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e67574cc71cb18ecdcbc26787907fe7
https://doi.org/10.1080/10428190400002285
https://doi.org/10.1080/10428190400002285
Autor:
Waleska S. Pérez, Christopher Bredeson, Santiago Pavlovsky, Stephen D. Nimer, Donna E. Reece, P.L. McCarthy, Gerald J. Elfenbein, David H. Vesole, Cesar O. Freytes, Deborah Marcellus, Mei-Jie Zhang, Amy K. Keating, Daniel J. Weisdorf, Robert Peter Gale, John R. Wingard, Sergio Giralt, Sundar Jagannath, L. B. To, Morie A. Gertz, Dipnarine Maharaj, John Gibson, Peter H. Wiernik, Karen K. Ballen, Robert A. Kyle, Gustavo Milone
Publikováno v:
Bone Marrow Transplantation. 32:1135-1143
The role of autologous stem cell transplantation (AuSCT) in older multiple myeloma patients is unclear. Using data from the Autologous Blood and Marrow Transplant Registry, we compared the outcome of 110 patients/=the age of 60 (median 63; range 60-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4636f175a0dce5bb86bd80dfe90382b4
https://doi.org/10.1038/sj.bmt.1704288
https://doi.org/10.1038/sj.bmt.1704288
Publikováno v:
Journal of Clinical Psychology in Medical Settings. 10:27-34
This study was conducted to develop an objective problems-in-living scale to identify the needs of cancer survivors after a demanding treatment such as bone marrow transplantation (BMT). A total of 99 adult BMT survivors completed questionnaires cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ce881842b58857a9f72881b2fbae66f
https://doi.org/10.1023/a:1022801713046
https://doi.org/10.1023/a:1022801713046
Autor:
John P. Leonard, Jane N. Winter, Sonali M. Smith, Louis S. Constine, Deborah Marcellus, Glenn Mills, Michael LeBlanc, Thomas C. Shea, Stephen J. Forman, Stephen Couban, Pierluigi Porcu, Lisa M. Rimsza, Patrick J. Stiff, Kevin Barton, Richard I. Fisher, James R. Cook, Douglas A. Stewart, Jonathan W. Friedberg, Hongli Li, Brad S. Kahl
Publikováno v:
Blood. 128:4651-4651
Background: We recently clarified the use of consolidative autologous stem cell transplantation (ASCT) as first remission consolidation therapy for high grade diffuse aggressive T and B non-Hodgkin's lymphoma (NHL)in patients with high-intermediate (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bbb8de2906dc926173c8e079a2d5371
https://doi.org/10.1182/blood.v128.22.4651.4651
https://doi.org/10.1182/blood.v128.22.4651.4651
Autor:
William R. Drobyski, M. Salama, Robert H. Collins, Matthew Johnson, Deborah Marcellus, A. Kirk, Austin John Barrett, Sergio Giralt, John E. Levine, Pablo M. Parker, David L. Porter, Thomas J. Nevill, Mary M. Horowitz
Publikováno v:
Bone Marrow Transplantation. 26:1179-1184
Donor leukocyte infusion (DLI) has well-documented activity in CML, but the role of DLI in other diseases is less well defined. To evaluate the strategy in multiple myeloma (MM) we evaluated 25 MM patients from 15 centers who were treated with DLI. P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a46286ac76b7eb56496ebf459718332d
https://doi.org/10.1038/sj.bmt.1702685
https://doi.org/10.1038/sj.bmt.1702685